Translocation t(11;14) (q13;q32) and genomic imbalances in multi-ethnic multiple myeloma patients: A Malaysian study

Hematology Reports

Volumn 4, Issue 3, 2012, Pages 60-65

  Pau Ni, Ivyna Bong ^a   Ching, Ng Ching ^b   Meng, Chang Kian ^c   Zakaria, Zubaidah ^a  

^a INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c Jalan Ampang   (Malaysia)

Author keywords

Copy number variations; Immunoglobulin heavy chain; IVNS1ABP; NAMPT; STK17B

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PROTEIN BCL 10; STAT1 PROTEIN;

ACSL1 GENE; ADOLESCENT; ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; ATP8B4 GENE; CANCER PROGNOSIS; CANCER RECURRENCE; CHROMOSOME ABERRATION; CHROMOSOME IDENTIFICATION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; ETHNICITY; FBXL5 GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE LOCATION; GENE LOCUS; GENETIC DISORDER; GENETIC GAIN; GENOMIC IMBALANCE; HUMAN; IRF2BP2 GENE; IVNS1ABP GENE; LAMP2 GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NAMPT GENE; NUCLEOTIDE SEQUENCE; PICALM GENE; POLYMERASE CHAIN REACTION; SAMSN1 GENE; STAT1 GENE; STK17B GENE;

EID: 84871055882     PISSN: 20388322     EISSN: 20388330     Source Type: Journal    
DOI: 10.4081/hr.2012.e19     Document Type: Article

References (43)

1. Bhardwaj A, Sethi G, Vadhan-Raj S, et al. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 2007;109:2293-302.
2. Chesi M, Bergsagel PL, Brents LA, et al. Dysregulation of cyclin D1 by translocation into an IgH switch region in two multiple myeloma cell lines. Blood 1996;88:674-81.
3. Bergsagel PL, Chesi M, Brents LA, et al. Translocations into IgH switch regions--the genetic hallmark of multiple myeloma. Blood 1995;86:223-33.
4. Chang H, Qi XY, Stewart AK. t(11;14) does not predict long-term survival in myeloma. Leukemia 2005;19:1078-9.
5. Fenton JAL, Pratt G, Rothwell DG, et al. Translocation t(11;14) in multiple myeloma. Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination. Genes, Chromosomes Cancer 2004;39:151-5.
6. Hoyer J, Hanson CA, Fonseca R, et al. The (11;14)(q13;q32) translocation in multiple myeloma: a morphologic and immunohistochemical study. Am J Clin Pathol 2000;113:831-7.
7. Fonseca R, Blood EA, Oken MM, et al. Myeloma and t(11;14)(q13;q32): evidence for a biologically defined unique subsets of patients. Blood 2002;99:3735-41.
8. Moreau P, Facon T, Leleu X, et al. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood 2002;100:1579-83.
9. Hallek M, Bergsagel PL, Anderson KC. Multiple myeloma: increasing evidence for a multistep transformation process. Blood 1998;91:3-21.
10. Jaillard S, Drunat S, Bendavid C, et al. Identification of gene copy number variations in patients with mental retardation using array-CGH: novel syndromes in a large French series. Eur J Med Genet 2010;53:66-75.
11. Shen Y, Irons M, Miller DT, et al. Development of a focused oligonucleotidearray comparative genomic hybridization chip for clinical diagnosis of genomic imbalance. Clin Chem 2007;53:2051-9.
12. Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony enhancing factor. Mol Cell Biol 1994;14: 1431-7.
13. Ognjanovic S, Bao S, Yamamoto SY, et al. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001;26: 107-17.
14. Martin PR, Shea RJ, Mulks M. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J Bacteriol 2001;183: 1168-74.
15. Wang B, Hasan MK, Alvarado E, et al. NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 2011;30: 907-21.
16. Van Beijnum JR, Moerkerk PT, Gerbers AJ, et al. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 2002;101:118-27.
17. Hufton SE, Moerkerk PT, Brandwijk R, et al. A profile of differentially expressed genes in primary colorectal cancer using suppression substractive hybridization. FEBS Lett 1999;463:77-82.
18. Hageman GJ, Stierum RH. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat Res 2001;475:45-56.
19. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
20. Nomura F, Yaguchi M, Togawa A, et al. Enhancement of poly-adenosine diphosphate-ribosylation in human hepatocellular carcinoma. J Gastroenterol Hepatol 2000;15:529-35.
21. Hasmann M, Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 2003;63:7436.
22. Koeppel M, van Heeringen SJ, Smeenk l, et al. The novel p53 target gene IRF2BP2 participates in cell survival during the p53 stress response. Nucleic Acids Res 2009; 37:322-35.
23. Childs KS, Goodbourn S. Identification of novel co-repressor molecules for interferon regulatory factor-2. Nucleic Acids Res 2003;31:3016-26.
24. Blotta S, Tassone P, Prabhala RH, et al. Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance. Blood 2009;114:3276-84.
25. Marzin Y, Jamet D, Douet-guilbert N, et al. Chromosome 1 abnormalities in multiple myeloma. Anticancer Res 2006;26:953-60.
26. Sawyer JR, Tricot G, Lukacs JL, et al. Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q. Genes Chromosomes Cancer 2005;42:95-106.
27. Zhan F, Colla S, Wu X, et al. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2-and p27Kip1-dependent and-independent mechanisms. Blood 2007;109:4995-5001.
28. Savage NM, Kota V, Manaloor EJ, et al. Acute leukemia with PICALM-MLLT10 fusion gene: diagnostic and treatment struggle. Cancer Genet Cytogenet 2010;202:129-32.
29. Sindt A, Deau B, Brahim W, et al. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9. Genes Chromosomes Cancer 2006;45:575-82.
30. Largo C, Alvarez S, Saez B et al. Identi-fication of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma. Haemato-logica 2006;91:184-91.
31. Zhu YX, Benn S, Li ZH, et al. The SHS-SAM adapter HACS1 is upregulated in B cell activation signalling cascades. J Exp Med 2004;200:737-47.
32. Claudio JO, Zhu YX, Benn SJ, et al. HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant haematopoietic cells. Oncogene 2001;20:5373-7.
33. Brandt S, Ellwanger K, Beuter-Gunia C, et al. SLy2 targets the nuclear SAP30/HDAC1 complex. Int J Biochem Cell Biol 2010;42: 1472-81.
34. Darnell JEJr. STATs and gene regulation. Science 1997;277:1630-5.
35. Bowman T, Jove R. STAT proteins and cancer. Cancer Control 1999;6:615-9.
36. Ogata A, Chauhan D, Teoh G, et al. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol 1997;159:2212-21.
37. Ishikawa H, Tsuyama N, Liu S, et al. Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals. Oncogene 2005;24:6328-32.
38. Fryknäs M, Dhar S, Oberg F, et al. STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer 2006;120:189-95.
39. Miura Y, Tsujioka T, Nishimura Y, et al. TRAIL expression up-regulated by interferon-gamma via phosphorylation of STAT1 induces myeloma cell death. Anticancer Res 2006;26:4115-24.
40. Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999;10:105-15.
41. Sanjo H, Kawai T, DRAKs AS. Novel serine/threonine kinases related to deathassociated protein kinase that trigger apoptosis. J Biol Chem 1998;273:29066-71.
42. Capra M, Nuciforo PG, Confalonieri S, et al. Frequent alterations in the expression of serine/threonine kinases in human cancers. Cancer Res 2006;66:8147-54.
43. Bergsagel PL, Michael Kuehl W. Chromosome translocations in multiple myeloma. Oncogene 2001;20:5611-22.